248 related articles for article (PubMed ID: 29540727)
21. HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression.
Jang EJ; Baek SE; Kim EJ; Park SY; Kim CD
Vascul Pharmacol; 2019; 118-119():106559. PubMed ID: 30954689
[TBL] [Abstract][Full Text] [Related]
22. Upregulation of miR-107 expression following hyperbaric oxygen treatment suppresses HMGB1/RAGE signaling in degenerated human nucleus pulposus cells.
Niu CC; Lin SS; Yuan LJ; Lu ML; Ueng SWN; Yang CY; Tsai TT; Lai PL
Arthritis Res Ther; 2019 Jan; 21(1):42. PubMed ID: 30704538
[TBL] [Abstract][Full Text] [Related]
23. HMGB1 may act via RAGE to promote angiogenesis in the later phase after intracerebral hemorrhage.
Lei C; Zhang S; Cao T; Tao W; Liu M; Wu B
Neuroscience; 2015 Jun; 295():39-47. PubMed ID: 25813710
[TBL] [Abstract][Full Text] [Related]
24. Role of Glycated High Mobility Group Box-1 in Gastric Cancer.
Kishi S; Nishiguchi Y; Honoki K; Mori S; Fujiwara-Tani R; Sasaki T; Fujii K; Kawahara I; Goto K; Nakashima C; Kido A; Tanaka Y; Luo Y; Kuniyasu H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068442
[TBL] [Abstract][Full Text] [Related]
25. Role of the high mobility group box 1 signalling axes via the receptor for advanced glycation end-products and toll-like receptor-4 in the immunopathology of oral lichen planus: a potential drug target?
Salem A; Almahmoudi R; Vehviläinen M; Salo T
Eur J Oral Sci; 2018 Jun; 126(3):244-248. PubMed ID: 29676511
[TBL] [Abstract][Full Text] [Related]
26. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.
Bassi R; Giussani P; Anelli V; Colleoni T; Pedrazzi M; Patrone M; Viani P; Sparatore B; Melloni E; Riboni L
J Neurooncol; 2008 Mar; 87(1):23-33. PubMed ID: 17975708
[TBL] [Abstract][Full Text] [Related]
27. HMGB1 attenuates TGF-β-induced epithelial-mesenchymal transition of FaDu hypopharyngeal carcinoma cells through regulation of RAGE expression.
Li Y; Wang P; Zhao J; Li H; Liu D; Zhu W
Mol Cell Biochem; 2017 Jul; 431(1-2):1-10. PubMed ID: 28285361
[TBL] [Abstract][Full Text] [Related]
28. High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway.
Shang D; Peng T; Gou S; Li Y; Wu H; Wang C; Yang Z
Sci Rep; 2016 Aug; 6():32180. PubMed ID: 27572515
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the HMGB1/RAGE axis protects against cisplatin-induced ototoxicity via suppression of inflammation and oxidative stress.
Qiao X; Li W; Zheng Z; Liu C; Zhao L; He Y; Li H
Int J Biol Sci; 2024; 20(2):784-800. PubMed ID: 38169643
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of HMGB1-RAGE in Kawasaki disease with coronary artery injury.
Qian B; Huang H; Cheng M; Qin T; Chen T; Zhao J
Eur J Med Res; 2020 Mar; 25(1):8. PubMed ID: 32183905
[TBL] [Abstract][Full Text] [Related]
31. Receptor for advanced glycation end products (RAGE) signaling induces CREB-dependent chromogranin expression during neuronal differentiation.
Huttunen HJ; Kuja-Panula J; Rauvala H
J Biol Chem; 2002 Oct; 277(41):38635-46. PubMed ID: 12167613
[TBL] [Abstract][Full Text] [Related]
32. The role of HMGB1-RAGE axis in migration and invasion of hepatocellular carcinoma cell lines.
Chen RC; Yi PP; Zhou RR; Xiao MF; Huang ZB; Tang DL; Huang Y; Fan XG
Mol Cell Biochem; 2014 May; 390(1-2):271-80. PubMed ID: 24510323
[TBL] [Abstract][Full Text] [Related]
33. Activation of the High Mobility Group Box 1/Receptor for Advanced Glycation Endproducts /NOD-like Receptor Family Pyrin Domain-Containing 3 Axis Under Chronic Intermittent Hypoxia Induction Promotes the Progression of Atherosclerosis in ApoE
Tan H; Hu J; Zuo W; Huang Y; Cui J; Gong F; Bai W
J Am Heart Assoc; 2023 Apr; 12(8):e024397. PubMed ID: 37026550
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases.
Singh H; Agrawal DK
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364135
[TBL] [Abstract][Full Text] [Related]
35. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
[TBL] [Abstract][Full Text] [Related]
36. S100A12 inhibits fibroblast migration via the receptor for advanced glycation end products and p38 MAPK signaling.
Tanaka N; Ikari J; Anazawa R; Suzuki M; Katsumata Y; Shimada A; Suzuki E; Matsuura Y; Kawata N; Tada Y; Tatsumi K
In Vitro Cell Dev Biol Anim; 2019 Sep; 55(8):656-664. PubMed ID: 31297698
[TBL] [Abstract][Full Text] [Related]
37. The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway.
Ren L; Lou Y; Sun M
Bioengineered; 2021 Dec; 12(1):5985-5995. PubMed ID: 34477479
[TBL] [Abstract][Full Text] [Related]
38. Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.
Ma F; Kouzoukas DE; Meyer-Siegler KL; Westlund KN; Hunt DE; Vera PL
BMC Physiol; 2017 May; 17(1):6. PubMed ID: 28545586
[TBL] [Abstract][Full Text] [Related]
39. High-mobility group box-B1 (HMGB1) mediates the hypoxia-induced mesenchymal transition of osteoblast cells via activating ERK/JNK signaling.
Qiu Y; Chen Y; Zeng T; Guo W; Zhou W; Yang X
Cell Biol Int; 2016 Nov; 40(11):1152-1161. PubMed ID: 27106169
[TBL] [Abstract][Full Text] [Related]
40. Activation of the high-mobility group box 1 protein-receptor for advanced glycation end-products signaling pathway in rats during neurogenesis after intracerebral hemorrhage.
Lei C; Wu B; Cao T; Zhang S; Liu M
Stroke; 2015 Feb; 46(2):500-6. PubMed ID: 25538203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
